174 related articles for article (PubMed ID: 38369709)
21. Addressing the soy and breast cancer relationship: review, commentary, and workshop proceedings.
Messina M; McCaskill-Stevens W; Lampe JW
J Natl Cancer Inst; 2006 Sep; 98(18):1275-84. PubMed ID: 16985246
[TBL] [Abstract][Full Text] [Related]
22. Soy and isoflavone consumption and subsequent risk of prostate cancer mortality: the Japan Public Health Center-based Prospective Study.
Sawada N; Iwasaki M; Yamaji T; Shimazu T; Inoue M; Tsugane S;
Int J Epidemiol; 2020 Oct; 49(5):1553-1561. PubMed ID: 32968784
[TBL] [Abstract][Full Text] [Related]
23. Cancer prevention with promising natural products: mechanisms of action and molecular targets.
Pratheeshkumar P; Sreekala C; Zhang Z; Budhraja A; Ding S; Son YO; Wang X; Hitron A; Hyun-Jung K; Wang L; Lee JC; Shi X
Anticancer Agents Med Chem; 2012 Dec; 12(10):1159-84. PubMed ID: 22583402
[TBL] [Abstract][Full Text] [Related]
24. Rodent Models Assessing Mammary Tumor Prevention by Soy or Soy Isoflavones.
Moorehead RA
Genes (Basel); 2019 Jul; 10(8):. PubMed ID: 31357528
[TBL] [Abstract][Full Text] [Related]
25. The role of soy isoflavones in menopausal health: report of The North American Menopause Society/Wulf H. Utian Translational Science Symposium in Chicago, IL (October 2010).
North American Menopause Society
Menopause; 2011 Jul; 18(7):732-53. PubMed ID: 21685820
[TBL] [Abstract][Full Text] [Related]
26. Ononin promotes radiosensitivity in lung cancer by inhibiting HIF-1α/VEGF pathway.
Zhang YM; Miao ZM; Chen YP; Song ZB; Li YY; Liu ZW; Zhou GC; Li J; Shi LL; Chen Y; Zhang SZ; Xu X; He JP; Wang JF; Zhang LY; Liu YQ
Phytomedicine; 2024 Mar; 125():155290. PubMed ID: 38308918
[TBL] [Abstract][Full Text] [Related]
27. Dietary soy and isoflavone intake and risk of colorectal cancer in the Japan public health center-based prospective study.
Akhter M; Inoue M; Kurahashi N; Iwasaki M; Sasazuki S; Tsugane S;
Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2128-35. PubMed ID: 18708407
[TBL] [Abstract][Full Text] [Related]
28. Differential effect of soy isoflavones in enhancing high intensity radiotherapy and protecting lung tissue in a pre-clinical model of lung carcinoma.
Hillman GG; Singh-Gupta V; Hoogstra DJ; Abernathy L; Rakowski J; Yunker CK; Rothstein SE; Sarkar FH; Gadgeel S; Konski AA; Lonardo F; Joiner MC
Radiother Oncol; 2013 Oct; 109(1):117-25. PubMed ID: 24021346
[TBL] [Abstract][Full Text] [Related]
29. Benzo(a)pyrene induced lung cancer: Role of dietary phytochemicals in chemoprevention.
Kasala ER; Bodduluru LN; Barua CC; Sriram CS; Gogoi R
Pharmacol Rep; 2015 Oct; 67(5):996-1009. PubMed ID: 26398396
[TBL] [Abstract][Full Text] [Related]
30. Rationale for the use of genistein-containing soy matrices in chemoprevention trials for breast and prostate cancer.
Barnes S; Peterson TG; Coward L
J Cell Biochem Suppl; 1995; 22():181-7. PubMed ID: 8538197
[TBL] [Abstract][Full Text] [Related]
31. Chemoprevention of prostate cancer: what can be recommended to patients?
Colli JL; Amling CL
Curr Urol Rep; 2009 May; 10(3):165-71. PubMed ID: 19371472
[TBL] [Abstract][Full Text] [Related]
32. Intake of Soy, Soy Isoflavones and Soy Protein and Risk of Cancer Incidence and Mortality.
Fan Y; Wang M; Li Z; Jiang H; Shi J; Shi X; Liu S; Zhao J; Kong L; Zhang W; Ma L
Front Nutr; 2022; 9():847421. PubMed ID: 35308286
[TBL] [Abstract][Full Text] [Related]
33. Dietary agents in cancer prevention: flavonoids and isoflavonoids.
Birt DF; Hendrich S; Wang W
Pharmacol Ther; 2001; 90(2-3):157-77. PubMed ID: 11578656
[TBL] [Abstract][Full Text] [Related]
34. Nuclear receptors - target molecules for isoflavones in cancer chemoprevention.
Bialešová L; Brtko J; Lenko V; Macejová D
Gen Physiol Biophys; 2013 Dec; 32(4):467-78. PubMed ID: 24067281
[TBL] [Abstract][Full Text] [Related]
35. Risks and benefits of dietary isoflavones for cancer.
Andres S; Abraham K; Appel KE; Lampen A
Crit Rev Toxicol; 2011 Jul; 41(6):463-506. PubMed ID: 21438720
[TBL] [Abstract][Full Text] [Related]
36. Soy, isoflavones, and prostate cancer.
Jian L
Mol Nutr Food Res; 2009 Feb; 53(2):217-26. PubMed ID: 18985655
[TBL] [Abstract][Full Text] [Related]
37. The potential of soybean foods as a chemoprevention approach for human urinary tract cancer.
Su SJ; Yeh TM; Lei HY; Chow NH
Clin Cancer Res; 2000 Jan; 6(1):230-6. PubMed ID: 10656454
[TBL] [Abstract][Full Text] [Related]
38. Soy isoflavones' osteoprotective role in postmenopausal women: mechanism of action.
Arjmandi BH; Smith BJ
J Nutr Biochem; 2002 Mar; 13(3):130-137. PubMed ID: 11893477
[TBL] [Abstract][Full Text] [Related]
39. Dietary soy isoflavones increase metastasis to lungs in an experimental model of breast cancer with bone micro-tumors.
Yang X; Belosay A; Hartman JA; Song H; Zhang Y; Wang W; Doerge DR; Helferich WG
Clin Exp Metastasis; 2015 Apr; 32(4):323-33. PubMed ID: 25749878
[TBL] [Abstract][Full Text] [Related]
40. Isoflavonoid levels in spot urine are associated with frequency of dietary soy intake in a population-based sample of middle-aged and older Chinese in Singapore.
Seow A; Shi CY; Franke AA; Hankin JH; Lee HP; Yu MC
Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):135-40. PubMed ID: 9488588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
